ASHLEY LITTLE: Open Payments
NPI 1770705121 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 45 payments from 16 companies in 2025. Trend: 2023 $537 · 2024 $796 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $161 |
| Lilly USA, LLC | 9 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Novo Nordisk Inc | 3 | $54 |
| Exact Sciences Corporation | 2 | $49 |
| Abbott Laboratories | 2 | $39 |
| Verona Pharma, Inc. | 2 | $36 |
| Dexcom, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
Products named: BREZTRI, MOUNJARO, TRELEGY ELLIPTA, Cologuard Collection Kit, FREESTYLE LIBRE, Ozempic, Ohtuvayre, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
